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Background: Two intracellular proteins, MMACHC and MMADHC, functionally interact for cobalamin trafficking.
Results:MMADHC crystal structure reveals protein-interacting regions and unexpected homology to MMACHC; mutations
on either protein interfere with complex formation via different mechanisms.
Conclusion: Complex formation likely depends on prior cobalamin processing and can be broken by disease mutations.
Significance: MMACHC-MMADHC heterodimerization forms the essential trafficking chaperone delivering cobalamin to
client enzymes.
Conversion of vitamin B12 (cobalamin, Cbl) into the cofactor
forms methyl-Cbl (MeCbl) and adenosyl-Cbl (AdoCbl) is
required for the function of two crucial enzymes, mitochondrial
methylmalonyl-CoAmutase and cytosolicmethionine synthase,
respectively. The intracellular proteins MMACHC and
MMADHC play important roles in processing and targeting the
Cbl cofactor to its destination enzymes, and recent evidence
suggests that theymay interact while performing these essential
trafficking functions. To better understand the molecular basis
of this interaction, we have mapped the crucial protein regions
required, indicate that Cbl is likely processed by MMACHC
prior to interaction withMMADHC, and identify patient muta-
tions on both proteins that interfere with complex formation,
via different mechanisms. We further report the crystal struc-
ture of the MMADHC C-terminal region at 2.2 Å resolution,
revealing a modified nitroreductase fold with surprising homo-
logy to MMACHC despite their poor sequence conservation.
BecauseMMADHCdemonstrates no known enzymatic activity,
we propose it as the first protein known to repurpose the
nitroreductase fold solely for protein-protein interaction. Using
small angle x-ray scattering, we reveal the MMACHC-
MMADHC complex as a 1:1 heterodimer and provide a struc-
tural model of this interaction, where the interaction region
overlaps with the MMACHC-Cbl binding site. Together, our
findings provide novel structural evidence and mechanistic
insight into an essential biological process, whereby an intracel-
lular “trafficking chaperone” highly specific for a trace element
cofactor functions via protein-protein interaction, which is dis-
rupted by inherited disease mutations.
Vitamin B12 (referred hereafter as cobalamin, Cbl)5 is an
essential cofactor for two human enzymes: cytosolic methio-
nine synthase (MS, EC 2.1.1.13), which requires methyl-Cbl
(MeCbl), and mitochondrial methylmalonyl-CoA mutase
(MUT, EC 5.4.99.2), which requires adenosyl-Cbl (AdoCbl) (1).
An intracellular pathway of at least seven human gene loci has
evolved, encoding proteins responsible for the transport, pro-
cessing and delivery of the appropriate Cbl form via a cytosol-
targeted route to MS, and a mitochondrion-targeted route to
MUT (2, 3). Mutations in any of the seven genes, depending on
its relative position within the pathway, can result in three
broad disease phenotypes collectively referred to as “intracellu-
lar Cbl disorders” (2, 4). They include (i) homocystinuria (HC)
associated with reduced MeCbl production and MS deficiency
(1, 5), (ii) methylmalonic aciduria (MMA) associated with
reduced AdoCbl production and MUT deficiency (6, 7), or (iii)
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a combinedHC andMMAdefect (HCMMA) (4).MMACHC
and MMADHC are two proteins involved in the early Cbl pro-
cessing steps that are shared by both mitochondrial and cyto-
solic targeting routes.MMACHC gene mutations are the most
common cause of Cbl metabolic disorders, resulting in
HCMMA (8). Genetic defects of MMADHC, by contrast,
uniquely cause any of the above three phenotypes (9, 10).
A possible explanation for the heterogeneous MMADHC
phenotypes is the presence of distinct functional domains at the
MMADHC protein level, responsible for trafficking to either
mitochondrial MUT (of AdoCbl) or cytosolic MS (of MeCbl),
or both. This hypothesis is supported by analysis of metabolic
phenotypes from known disease mutations (11) and alanine-
scanning mutagenesis (12). These studies dissect the 296-
amino acid (aa) human MMADHC polypeptide functionally
into the N-terminal 115 aa that is required for the mitochon-
drial route but dispensable for cytosolic trafficking, the C-
terminal 180 aa that contribute to both routes, and two regions
therein (aa 197–226 and 246–259) that have greater influence
on the cytosolic than the mitochondrial route. Current knowl-
edge points to a role of MMADHC in regulating Cbl delivery at
the branch point between the mitochondrial and cytoplasmic
target enzymes, albeit via an incompletely understood
mechanism.
Furthermore, despite the MMADHC gene discovery seven
years ago (10), few of the biochemical properties and functions
of theMMADHCprotein are known. Although previously pos-
tulated to containCbl andATPbindingmotifs (10),MMADHC
has been shown not to bind Cbl (13) or to hydrolyze ATP (14).
Further biochemical exploration has been hampered in part by
a lack of structural knowledge or sequence homologues. The
inability of MMADHC to bind Cbl has implicated protein-pro-
tein interaction as the means of its Cbl-targeting role. This is
supported by recent evidence from phage display (13, 15), bac-
terial two-hybrid studies (15), native PAGE (14), and surface
plasmon resonance (13, 15) that MMADHC interacts directly
with MMACHC in vitro (13, 15), and the interaction does not
require the N-terminal 115 aa of MMADHC (14). Because
MMACHC has been shown structurally (16, 17) and biochem-
ically (18, 19) to bind various Cbl forms, and to process the
upper Cbl ligand by reductive decyanation (19) or dealkylation
(20) using the flavin cofactors FMN/FAD and GSH, respec-
tively, it seems plausible that MMACHC-bound Cbl can part-
ner with MMADHC to be ferried to the two destination
enzymes.
To evaluate the importance and molecular basis of the
MMACHC-MMADHC interaction, we have defined aminimal
MMACHC interaction module of MMADHC, and demon-
strated that experimental and patient missense mutations dis-
rupt this interaction.We have further determined the structure
of this interaction module from mouse MMADHC to 2.2 Å
resolution, and established the 1:1 stoichiometry of the
MMACHC-MMADHC heterodimer using small angle x-ray
scattering (SAXS). Finally, based on the combined findings, we
propose the first structural model of the MMACHC-
MMADHC interaction.
Experimental Procedures
Recombinant Production of MMACHC and MMADHC—
DNA fragments encoding human (Homo sapiens, IMAGE
clone: 3826071) and mouse (Mus musculus, IMAGE clone:
3493526) MMADHC, harboring different N- and C-terminal
boundaries, were amplified and subcloned into pNIC28-Bsa4
vector (GenBankTM accession number EF198106) in-frame
TABLE 1
Data collection and refinement statistics forMmMMADHC structure
MmMMADHC128 SeMeta MmMMADHC128 nativeb
Data collection and processingc
Beamline Diamond I04 Diamond I04
Wavelength (Å) 0.9782 0.9782
Unit cell parameters a, b, c (Å) 73.5 88.7 65.7 74.2 89.5 64.7
Unit cell parameters , ,  (°) 90.00 90.00 90.00 90.00 90.00 90.00
Space group C 2 2 21 C 2 2 21
Resolution range (Å) 44.33–2.61 (2.68–2.61) 44.76–2.25 (2.31–2.25)
Observed/Unique reflections 78,726/6293 (6117/471) 51,530/10,530 (3778/762)
Rsym (%) 12.2 (54.8) 2.5 (59.8)
CC1/2 0.99 (0.96) 1.0 (0.80)
I/(I) 15.1 (4.7) 31.6 (2.6)
Completeness (%) Anomalous 92.1 (98.8) 99.8 (99.6)
Multiplicity Anomalous 6.7 (6.8) 4.9 (5.0)
Refinement
Rcryst (%) 22.9
Rfree (%) 25.5
Wilson B factor (Å2) 55.5
Average total B factor (Å2) 66.2
r.m.s.d. bond length (Å2) 0.0034
r.m.s.d. bond angle (°) 0.87
Missing residues 129–131, 160–168, 237–245
MolProbity analysis
Clashscore 5.98 (98th percentile)
Ramachandran favored (%) 96.48%
Ramachandran disallowed (%) 0.00%
Rotamer outliers (%) 0.00%
PDB code 5A4R
a Crystallization condition: 28% PEG3350, 100 mM Bis-Tris, pH 6.5, 250 mM NaCl.
b Crystallization condition: 22% polyacrylic acid 5100, 100 mM HEPES, pH 7.5, 20 mM MgCl2.
c Data from highest resolution shell are shown in parentheses.
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with a tobacco etch virus protease cleavable N-terminal His6
tag. Constructs of humanHsMMACHC inpNIC28-Bsa4 vector
were prepared previously (16, 21). Site-directedmutationswere
constructed using the QuikChange mutagenesis kit (Strat-
agene) and confirmed by sequencing. Cloning and site-directed
mutagenesis primers are available upon request. Proteins were
expressed in Escherichia coli BL21(DE3)R3 and purified by
affinity (Ni-Sepharose; GE Healthcare) and size-exclusion
(Superdex 200; GE Healthcare) chromatography. For crystalli-
zation, MMADHC proteins were further purified by ion
exchange chromatography (Resource Q; GE Healthcare). Sel-
enomethionine (SeMet)-derivatized proteins were expressed
using SelenoMethionine Medium Complete (Molecular Di-
mensions) and purified as above.
Crystallization and Structural Determination—Purified
SeMet-derivatized and native MmMMADHC128 were con-
centrated to 15–20 mg/ml, and crystals were grown by sitting
drop vapor diffusion at 4 °C. The mother liquor conditions are
summarized inTable 1. Crystals were cryo-protected inmother
liquor containing ethylene glycol (25% v/v) and flash-cooled in
liquid nitrogen. X-ray diffraction datawere collected at theDia-
mond Light Source beamline I04 and processed using XIA2.
Selenium atoms were located using SHELXC/D (22) for initial
phase calculation in SHELXE, and subsequently for automated
building with BUCCANEER (23). The structure was solved by
selenium single-wavelength anomalous diffraction phasing and
refined using PHENIX (24), followed by manual rebuilding in
COOT (25). The SeMet MMADHC model was used to solve
the native structure by molecular replacement using PHASER
(26). The final refined model consists of aa 132–157, 169–236,
and 246–296 of MmMMADHC. Atomic coordinates and
structure factors for MmMMADHC128 have been deposited
in the Protein Data Bank with the accession code 5A4R. Data
collection and refinement statistics are summarized in Table 1.
Small Angle X-ray Scattering—For SAXS, MMACHC and
MMADHC were cleaved by tobacco etch virus protease to
remove the N-terminal His6 tag, followed by reverse affinity
purification. Purified proteins were then incubated separately
or together with the appropriate ligands and further purified by
size-exclusion chromatography. Concentrations of proteins
used were 24mg/ml (MMADHC), 18mg/ml (MMACHC), and
17 mg/ml (complex). Scattering data were collected at the Dia-
mond Light Source B21 beamline. Data collection was per-
formed either in-line with size-exclusion chromatography
(KW404 column, Shodex) or in batch mode where the peak
fractions were collected and immediately subjected to SAXS by
flowing sample through an in-vacuum quartz capillary of
1.6-mm diameter. Data were collected using a Pilatus 2M
detector (DECTRIS, Baden, Switzerland) at a sample-detector
distance of 3914mm and a wavelength of  1 Å. The range of
momentum transfer of 0.1  s  5 nm1 was covered (s 
4sin/, where  is the scattering angle). For the in-linemode,
1-s exposures were collected, whereas for batch samples, a
comparison of eighteen 10-s exposures was performed. Radia-
tion damage was checked for the batch mode by monitoring
changes in radius of gyration in each frame, where no signifi-
cant changes were observed. The data were radially averaged,
and the scattering of the buffer was subtracted. The forward
scattering I(0), radius of gyration Rg, pair distribution of the
particle P(r), and maximum dimension Dmax were analyzed
using Scatter (27) and the ATSAS suite of programs (28).
Solution Characterization of MMACHC and MMADHC—
Blue native-PAGE was performed with 25 	M protein
(MMACHC and/or MMADHC) alone or in the presence of 50
	M cobalamin (MeCbl, AdoCbl, CNCbl) and/or 8 mM ligand
(GSH, FMN, FAD), whichwas loaded onto the native-PAGEgel
system, after preincubation in the dark at room temperature for
1 h, and then run following the manufacturer’s instructions
(Life Technologies). All blue native-PAGE experiments were
performed at least twice independently. Analytical gel filtration
(16), FMN/FAD binding by intrinsic fluorescence quenching
(17), and differential scanning fluorimetry (21, 29), were per-
formed as described previously. For native mass spectrometry,
75 	l of sample containing 4 mg/ml MMADHC and
MMACHC incubated in the presence of 0.5 mM MeCbl and 2
mM reduced GSH underwent four desalting steps using Micro
Bio-Spin columns (Bio-Rad) that were pre-equilibrated with 50
mM ammonium acetate buffer (pH 6.5). Following desalting,
samples were loaded into a 1.0-ml gas-tight positive displace-
ment syringe (Hamilton) that was inserted into the syringe
pump. Samples were then directly infused with a constant flow
rate of 6 	l/min through a PEEK capillary tubing (inner diam-
eter, 0.005 inches) into a Q-TOF 6530 mass spectrometer
attached to a standard electrospray ionization source (Agilent
Technologies). Themass spectrometerwas operated in positive
ion mode, using the 1-GHz detector mode with a scan range of
100–20,000m/z and a fragmentor voltage of 430 V. Following
data acquisition, results were evaluated by using the Mass-
Hunter Qualitative Analysis software (Agilent Technologies).
Results
MMADHC aa 154–296 Is an MMACHC Interaction
Module—To better understand the required regions, ligand
dependence, and stoichiometry of their in vitro interactions, we
generated a series of human (Hs) MMADHC and MMACHC
truncation proteins by recombinant expression (Fig. 1A). Using
blue native-PAGE (BN-PAGE) (Fig. 1B), full-lengthMMACHC
(HsMMACHCFL) alonemigrated as two bands (lane 1), consis-
tentwith its knownmonomeric and dimeric forms, whereas the
dimeric band became more prominent in the presence of
MeCbl andGSH (lane 2,white dot). TheHsMMADHCproteins
with various N-terminal truncations migrated as single bands
(lanes 3–8) corresponding to their respective monomers, cor-
roborating previous investigations (13). Complex formation, as
judged by the appearance of an additional band in BN-PAGE as
compared with single-protein controls, was observed when
HsMMACHCFL preincubated withMeCbl andGSHwas added
toHsMMADHC61 orHsMMADHC123, or to a lesser extent,
HsMMADHC153 (lanes 9–11, white asterisk). However,
no complex band was observed with N-terminal trunca-
tion of HsMMADHC beyond aa 154 (HsMMADHC157,
HsMMADHC167, or HsMMADHC172; lanes 12–14) under
the same conditions. The HsMMADHC-HsMMACHC com-
plex bandsmigrated at a position intermediate of the estimated
monomeric and dimeric HsMMACHC bands, suggesting a
possible 1:1 heterodimeric complex. HsMMACHCC, which
Characterization of theMMACHC-MMADHC Complex
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lacks the C-terminal Pro-rich region (aa 236–282; Fig. 1A),
was sufficient for complex formation withHsMMADHC123
(Fig. 1C, lane 2). Size-exclusion chromatography using
MmMMADHC128 andHsMMACHCC proteins further con-
firmed the regions required for interaction and the 1:1 stoichi-
ometry of the complex (Fig. 1D). Therefore, the MMADHC
region C-terminal to aa 154 and theMMACHC region without
the Pro-rich C terminus is sufficient for direct protein-protein
interaction. Notably, the MMADHC C-terminal region is the
most evolutionarily conserved section of the polypeptide from
human to Caenorhabditis elegans (Fig. 1E), suggesting selected
retention of this interaction module in evolution.
In agreement with previous work (14), complex formation is
favored by preincubation of proteins with GSH and MeCbl,
Characterization of theMMACHC-MMADHC Complex
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conditions known to facilitate upper Cbl ligand (R-group)
removal. We observed either significantly weaker or no inter-
action between HsMMACHCFL and HsMMADHC123 when
GSHwas replaced by other reducing factors (FMN, FAD, DTT)
or when MeCbl was replaced by other Cbl forms (AdoCbl,
CNCbl) (Fig. 1F), conditions known to result in much slower
(10-fold) or no R-group removal (30, 31). We further investi-
gated two HsMMACHCmutants with reduced MeCbl dealky-
lation activity (HsMMACHCPNR, missing aa 109–111 (16),
or HsMMACHCR161Q (16, 32)), on their ability to complex with
HsMMADHC123. Upon incubation withMeCbl and GSH, the
HsMMACHCR161Q mutant was less able than HsMMACHCFL
to complex with HsMMADHC123 (compare Fig. 1C, lane 4
with Fig. 1B, lane 10), whereasHsMMACHCPNR did not com-
plex with HsMMADHC123 at all (Fig. 1C, lane 6).
TheMMACHC-MMADHC interaction is further studied by
native mass spectrometry, where the complex of HsMMACH-
CFL andHsMMADHC123, incubated in the presence ofMeCbl
and GSH, generated two peaks consistent with a 1:1 stoichiom-
etry, one missing the 15 atomic mass units of the methyl group
(Fig. 1G, 52,875 atomic mass units) and the other missing 16
atomic mass units, corresponding to the methyl group plus the
hydrogen fromGSH (Fig. 1G, 53,181 atomic mass units). Thus,
R-group removal appears to be a prerequisite for MMACHC-
MMADHC interaction.
MMADHCContains a Nitroreductase-like Fold with Homol-
ogy toMMACHC—We next characterizedMMADHC by x-ray
crystallography to elucidate the molecular properties of its
MMACHC interaction module. To maximize the probability
of crystallization, we adopted a cross-species approach that
involved the study of recombinant human, M. musculus, and
Xenopus laevisMMADHC proteins, coupled with an extensive
survey of construct boundaries. From40 purified proteins, we
successfully crystallized M. musculus MMADHC aa 129–296
(MmMMADHC128; Figs. 1A and 2A), a region bearing 93%
identity with the human sequence. In our BN-PAGE assay,
MmMMADHC(e.g. MmMMADHC128) can substitute the
equivalent human construct in stable complex formation with
HsMMACHC (not shown). Despite repeated attempts, the
equivalent HsMMADHC construct did not crystallize. The
structure ofMmMMADHC128 (Fig. 2,A andB), determined to
2.6 Å resolution by single-wavelength anomalous dispersion
phasing for the selenomethionine (SeMet) derivative, and to 2.2
Å by molecular replacement for the native protein (Table 1), is
a mixed / domain composed of a central four-stranded
antiparallel -sheet (1, 2, 6, 3) flanked by a 14-turn helix
(B) and a short -turn (4-5) (Fig. 2C).
A structural comparison of MmMMADHC128 with other
proteins using DALI (33) revealed that the core structure is
derived from the nitroreductase (NTR) fold (Fig. 3A), primarily
found in flavoenzymes and oxidoreductases that utilize FMN/
FAD cofactors and form homodimers by -strand exchange, as
well as MMACHC (Fig. 3B). Nevertheless,MmMMADHC128
has extensively modified the NTR fold with three loop protru-
sions (Pr1–Pr3), rendering it functionally different from classi-
cal NTRs. Firstly,MmMMADHC128 does not bind FMN/FAD
in solution (data not shown) because the canonical binding site
found in NTRs is disrupted by part of the MMADHC Pr2
loop protrusion (Fig. 4A). Secondly, although in crystallo
MmMMADHC128 reveals a symmetry-related dimer, its
dimeric interface does not match that of the conventional
NTRs (Fig. 4B). Indeed, MmMMADHC128 is a monomer in
solution by BN-PAGE, size-exclusion chromatography (not
shown), and SAXS (see “A StructuralModel of theMMACHC-
MMADHC Complex”), consistent with HsMMADHC con-
structs migrating as monomers in BN-PAGE (Fig. 1B).
To our surprise, the closest structural homologue of
MMADHC is its interaction partner MMACHC (DALI (33)
Z-score, 5.2), despite a lack of obvious sequence conservation.
Like MMADHC, MMACHC contains three loop protrusions,
at equivalent spatial positions, in the core NTR fold (16, 17)
(Fig. 3B). MMACHC also lacks the classical FMN binding site
present among NTRs, while retaining the ability to bind flavins
in solution (17), likely involving a non-canonical binding site
(16). The MMADHC and MMACHC structures superimpose
only moderately and within the core NTR secondary structure
elements (C-r.m.s.d. 3.0 Å, 96 aligned aa), beyond which they
differ substantially (Fig. 3B). For example, MmMMADHC128
does not contain the four-helix cap domain and differs in length
and conformation of two protrusions as compared with
MMACHC, all of which form part of the MMACHC Cbl bind-
ing pocket (16, 17). These extensive structural differences from
MMACHC likely account for thereported lackofCblbindingcapa-
bility of MMADHC (13). We additionally found no sequence ele-
ments or homology consistentwithATPase activity.
Patient and Experimental MMADHC Mutations Knock Out
Interaction with MMACHC—Our previous mutagenesis stud-
ies in patient fibroblasts (11, 12) revealed specific MMADHC
FIGURE 1. Interaction study ofMMACHC andMMADHC. A, domain diagram showing recombinant humanMMACHC andMMADHC constructs described in
this figure. For reference,mouse constructMmMMADHC128 used to generate the crystal structure is also shown. B, interaction of humanMMACHC full-length
and MMADHC truncated proteins by BN-PAGE. Lanes 1–8: single protein controls including MMACHCFL alone (lane 1) and with MeCbl and GSH (lane 2); and
MMADHC truncations including MMADHC61 (lane 3), MMADHC123 (lane 4), MMADHC153 (lane 5), MMADHC157 (lane 6), MMADHC167 (lane 7),
andMMADHC172 (lane8). Lanes9–14: combinedprotein incubationofMMACHCFL inpresenceofMeCbl andGSHwithMMADHC61 (lane9),MMADHC123 (lane
10), MMADHC153 (lane 11), MMADHC157 (lane 12), MMADHC167 (lane 13), andMMADHC172 (lane 14). C, interaction ofMMACHCmutants andMMADHC123
by BN-PAGE, in the presence of MeCbl and GSH. Lanes 1–6: MMACHCC alone (lane 1) and with MMADHC123 (lane 2); MMACHCR161Q alone (lane 3) and with
MMADHC123 (lane 4); and MMACHCPNR alone (lane 5) and with MMADHC123 (lane 6). For B and C, white dots indicate MMACHC homodimer, and white
asterisks indicate MMACHC-MMADHC heterodimer. D, analysis of complex formation by size-exclusion chromatography including chromatographs of
MmMMADHC123 (gray line), HsMMACHCC  MeCbl  GSH (black line), and MmMMADHC123  HsMMACHCC  MeCbl  GSH (black dotted line). x axis:
elution volume; left y axis: absorbance (milliabsorbance units (mAU)) for HsMMACHCCMeCbl GSH; right y axis: absorbance (mAU) forMmMMADHC123
and MmMMADHC123  HsMMACHCC  MeCbl  GSH. Molecular weights of each peak are calculated from a calibration curve using molecular weight
protein standards (Sigma-Aldrich). E, sequence alignment ofMMADHC fromH. sapiens (HS, NP_056517.1, human) and predictedMMADHCprotein (Y76A2B.5)
from C. elegans (Ce) using the BLAST server (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The boxed region represents the smallest interacting construct of
HsMMADHC for HsMMACHC. F, BN-PAGE of HsMMACHCFL and HsMMADHC123 under various conditions. White asterisks indicate MMACHC-MMADHC het-
erodimer. G, native mass spectrometry of HsMMACHCFL and HsMMADHC123 incubated with MeCbl and GSH. Expected sizes: HsMMACHCFL, 31818.6 Da;
HsMMADHC123, 19727.7 Da; MeCbl, 1343.6 Da; and GSH, 307.3 Da.
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regions responsible for the intracellular targeting of the two
cobalamin cofactors. These mutations correlate with the
MMA, HC, or HCMMA phenotypes based on their amino
acid location (Fig. 5A). Missense mutations causing decreased
MeCbl production (HCphenotype) or bothAdoCbl andMeCbl
production (HCMMA phenotype) in cells are found within
three sequence stretches at the MMADHC C-terminal
half (Fig. 5A, stretches 1–3). When mapped onto our
MmMMADHC128 structure, these three stretches cluster
in spatial proximity and are surface-accessible (Fig. 5B).
We investigated whether these mutations impact on the
MMACHC-MMADHC interaction by introducing onto the
HsMMADHC123 construct a selection of HC and HCMMA
causing mutations from the three stretches (Stretch 1:
p.T182N, p.M186A, p.W189A; Stretch 2: p.D226A; Stretch 3:
p.L259P). The recombinant mutant proteins behaved similarly
to wild type in terms of expression level, protein solubility (not
shown), and thermal stability (Fig. 5C), where only p.D226A
led to slightly unstable protein. We found interaction of
HsMMACHCFL (incubated with MeCbl and GSH) with
HsMMADHC123-T182N and HsMMADHC123-W189A to be
severely decreased (Fig. 5D, lanes 3 and 5), but retained
for HsMMADHC123-M186A, HsMMADHC123-D226A, and
HsMMADHC123-L259P (Fig. 5D, lanes 4, 6, and 7). These find-
ings suggest that residues within Stretch 1 (Thr-182, Trp-189)
occur at the binding interface with MMACHC.
A StructuralModel of theMMACHC-MMADHCComplex—
We next utilized SAXS, a low-resolution structural character-
ization method in solution (34), to construct a model of the
MMACHC-MMADHC interaction. To ensure that the SAXS
data most closely resembled the ordered aa regions revealed
from the MMACHC and MMADHC structures, we reconsti-
tuted a complex from untagged MmMMADHC128 and
untagged HsMMACHCC proteins in the presence of MeCbl
and GSH. The Guinier approximation and pair distribution
function P(r) calculated from the scattering data (Fig. 6, A and
B) suggest a radius of gyration (Rg) of 24.7 Å andmaximal intra-
particle dimension (Dmax) of 80Å for the complex, both param-
eters larger than those from either protein component alone
(Fig. 6C). Further, the elution time of the protein complex from
the in-line HPLC column was earlier than either protein alone,
FIGURE 2. Structure of the MMACHC interaction module of MMADHC. A, graphic representation of the MmMMADHC128 structure in orthogonal views.
Secondary structures are colored green for-sheets and red for-helices. The first (aa 132) and last (aa 296) residues observed in the structure are labeledwith
N and C, respectively. Dotted lines indicate disordered regions. Inset: view of the -weighted (2Fo Fc) electron density map of MmMMADHC128 aa region
190–217, contoured at 1. B, surface representation ofMmMMADHC128 (same orientation as A, right panel) highlighting the three protrusions (Pr1–Pr3) in
blue. C, topology diagram of the MmMMADHC128 secondary structure with the same coloring and labeling as in A and B. Disordered regions are shown as
dashed lines.
FIGURE3.Structural comparisonofMMADHCandproteinsof thenitrore-
ductase family. A, structural superposition of MmMMADHC128 (red) and
two other NTRs (Protein Data Bank (PDB): 2HAY, 2ISL; gray). B, superposition
of MmMMADHC128 (red) and MMACHC (PDB: 3SOM; gray), highlighting the
absence of the HsMMACHC four-helix cap domain (aa 185–234) in
MmMMADHC128 as well as the different orientations of protrusions Pr1 and
Pr2 (HsMMACHC: Pr1 aa 69–77; Pr2 aa 104–116; MmMMADHC128: Pr1 aa
183–190, Pr2 aa 227–246) between the proteins. Protrusions (Pr1–Pr3) are
colored blue forMmMMADHC128 and yellow for HsMMACHC.
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giving rise to a calculated molecular weight consistent with a
1:1 stoichiometry (Fig. 6C). The ab initio envelope of the
MmMMADHC128-alone sample fits well to one monomer
(Fig. 6D). MMACHC is known to exist in a monomer:dimer
equilibrium (Fig. 1) (16), and the monomeric species selected
for SAXS analysis is consistent with one protomer in the ab
initio envelope (Fig. 6E). However, for the MMACHC-
MMADHC complex, the ab initio envelope (Fig. 6F) gives an
elongated dimension of 80, 40, and 40 Å. One protomer from
each of HsMMACHCC and MmMMADHC128 would
account for all themass of the envelope, further indicating a 1:1
heterodimeric stoichiometry that agrees with our BN-PAGE,
size-exclusion chromatography, and native mass spectrometry
data (Fig. 1). Although the relative orientation of both proteins
cannot be ascertained by SAXS, we applied our mutagenesis
and interaction data (Fig. 5) to direct protein docking of the
complex using the ZDOCK server (35), given that residue Thr-
182 of MmMMADHC should be involved in the interaction.
With this constraint, the top seven models generated from
ZDOCK (Fig. 6F) all yield a good fit (
2 0.03–0.04) to the
measured scattering. These models are consistent with an
MMACHC-MMADHC interface that involves the Cbl binding
region of MMACHC and aa 182–189 (Fig. 5, stretch 1) of
MMADHC (Fig. 6G). A similar docking run was performed
with HADDOCK (36), yielding consistent models (data not
shown).
Discussion
The role of MMACHC within the early stages of the Cbl
processing pathway has previously been clarified from the
available structural and biochemical evidence of its Cbl binding
and processing activities (16–20). By contrast, the role of
MMADHC, tasked with directing Cbl to the destination
enzymes yet unable to bind Cbl itself, is much less clear. This
study presents the first structural characterization of
MMADHC to provide novel insights into its unknown func-
tion, with the key findings that: (i) MMADHC functions by
binding Cbl-laden MMACHC, but only post-Cbl processing,
i.e. after the upper axial ligand of Cbl has been removed; (ii) the
MMACHC interactionmodule ofMMADHCcontains an inge-
FIGURE 4. Comparison of MMADHC to other NTR dimers. A, overlay of the MmMMADHC128 structure (red) with nitroreductases from Desulfovibrio desul-
furicans (PDB: 3E39), Streptococcus pyogenes (PDB: 2HAY), and Enterobacter cloacae (PDB: 1KQD). The canonical FMN/FADbinding site ofNTRs (left, indicatedby
the green stick ligand), located at the conventional dimer interface, is not present in MMADHC (right) due to disruption by its protrusion loop Pr2. B, structural
alignment of a single subunit (protomer A) ofMmMMADHC128 (MMADHC), HsMMACHCFL (MMACHC, PDB: 3SOM), and an NTR (PDB: 1KQD) in gray, with the
second subunit (protomer B) of their crystallographic dimers color-coded (MMADHC in blue; NTR in yellow; MMACHC in red), demonstrating the lack of a
conserved dimeric orientation and interface among the three structures.
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niously modified NTR fold that abolishes homodimerization,
favors heterodimerization with another modified NTR fold
from MMACHC, and accounts for the reported lack of Cbl
binding (13); and (iii) missense mutations of MMADHC that
reduced both AdoCbl and MeCbl production in cells can be
explained at least in part by an abrogated interaction with
MMACHC.
Our data illustrate the application of protein-protein inter-
action in the early Cbl-targeting steps of the pathway for both
the mitochondrial (AdoCbl to MUT) and the cytosolic (MeCbl
to MS) targeting routes. Such protein-protein interaction is
essential to the targeting process, and is disrupted by a known
disease mutation of MMACHC that precludes B12 processing
and bymutations ofMMADHC that alter the binding interface.
We propose a mechanistic model for the MMACHC-
MMADHC complex whereby the adaptation of the NTR fold
by both proteins favors heterodimerization to form the “Cbl
trafficking chaperone.” In this model, MMACHC in the Cbl-
free form could exist in a monomer-homodimer equilibrium
(Fig. 7A). The self-association of MMACHC into homodimer,
likely with a high dissociation rate that precludes its isolation in
vitro (13, 16, 17), is enriched in the presence of Cbl ligand (Fig.
7B) and may serve to close the enzymatic active site for proper
Cbl processing (16) (Fig. 7C). Cbl-ladenMMACHC(monomer/
homodimer), with the upper axial ligand now removed, prefer-
entially binds monomeric MMADHC as a 1:1 heterodimer
rather than binding to itself, resulting in the “trafficking chap-
erone” that delivers processed Cbl to its target destinations
(Fig. 7D).
Interestingly, only the C-terminal 154 aa of MMADHC
is required for the interaction with MMACHC. As such, the
exact function of the MMADHC N terminus remains to
be determined. Predicted to be largely disordered, the N-
terminal 115 aa harbors a mitochondrial targeting se-
quence (aa 1–12) and has been shown to be required for
cellular AdoCbl production only (11). Thus, this protein
FIGURE 5. Structural and biochemical analysis of MMADHCmissense mutations. A, domain diagram of MMADHC, with missense mutations color-coded
according to their cellular defects (10–12), namely MMA (green), combined HCMMA (stretch 1, red), or HC (stretches 2 and 3, blue) phenotypes. Purple line
indicates aa region observed in the crystal structure. B, graphic (left) and surface (right) representations ofMmMMADHC128 mapped with stretches 1–3 and
individualmutations foundwithin these regions.Dotted lines indicatedisordered regions.C, analysis of thermal unfoldingcurvesof variousprotein constructs reveals
amelting temperature (Tm) of 62 °C (right) forHsMMADHC123, which is relatively unchanged for all mutants with the exception ofHsMMADHC123-D226A where the
Tm is slightlydecreasedascomparedwithwild type.Errorbars indicatemeans	S.E.D, interactionofHsMMACHCFLwithwild-typeormutantHsMMADHC123 studied
by BN-PAGE. Depicted are: HsMMACHCFL with MeCbl and GSH alone (lane 1), and in combination with HsMMADHC123 (lane 2), HsMMADHC123-T182N (lane 3),
HsMMADHC123-M186A (lane4),HsMMADHC123-W189A (lane5),HsMMADHC123-D226A (lane6),andHsMMADHC123-L259P (lane7).Whiteasterisks indicatetheMMACHC-
MMADHCheterodimer.
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FIGURE 6.SAXSanalysis of theMMACHC-MMADHC interaction.A, raw scattering curves forMmMMADHC128 (red),HsMMACHCC (blue), and their complex
(black). B, P(r) plots, calculated with Scatter (27) and normalized to peak height, show differences between the single proteins and the complex. Guinier plots
indicate aggregation-free data. C, table of radius of gyration (Rg), maximal intraparticle dimension (Dmax) as calculated from the Guinier plot, apparent
molecular weight (MW), and elution time from the in-line HPLC column. D and E, ab initio bead models calculated with 13 runs of DAMMIF (39) for
MmMMADHC128 fitted with its x-ray structure (this study) (D) and HsMMACHCC fitted with its x-ray structure (PDB: 3SOM) (E). F, top seven models of the
HsMMACHCC-MmMMADHC128 complex produced by ZDOCK with fitted 

2 values shown. The SAXS envelope is overlaid with modeled orientations
of HsMMACHCC (blue) andMmMMADHC128 (red) structures.MmMMADHC128 is presented in the same orientation on all models for better comparison. G,
HsMMACHCC-MmMMADHC128 complex fitted with a representative example of the ZDOCK (35) complex model. In E and G, Cbl is shown as purple sticks.
FIGURE7.ProposedroleoftheMMACHC-MMADHCcomplexinCbltargeting.A,MMACHC(bluesector) intheunboundstateexistsprimarilyasamonomer.B,upon
bindingunprocessedCblwith an intact upper axial ligand (triangle), it can shift toward thehomodimeric state.C, followingprocessingofCbl (green to red triangle) via
GSH-mediated removal of its upper axial ligand (green stick and square), MMACHC is available for interaction with MMADHC (orange sector). D, MMADHC binds
MMACHC in a 1:1 heterodimer and escorts Cbl-ladenMMACHC either toward themitochondria (star) for use bymethylmalonyl-CoAMUT or toMS in the cytosol.
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region is likely only required for function within, or direction
to, the mitochondria.
BecauseMMADHCmutations that abolished direct interac-
tion with MMACHC result in the combined HCMMA phe-
notype (11, 12), it is conceivable that disruption of the
MMACHC-MMADHC complex will result in an inability to
deliver Cbl to both destination enzymes MS and MUT. A pos-
sible role of MMACHC in the mitochondria, where it has not
been detected either on its own or in complex (37), remains
undetermined. The dysfunction caused by MMADHC mis-
sense mutations, which result in a loss of MS activity only, i.e.
the so-called cblD-HC mutations (10), also remains unex-
plained. Because MMACHC has recently been shown to bind
various isoforms of MS (38), the cblD-HC mutations could
affect a larger, yet unidentified multi-protein complex, likely
including at least MMACHC and MS, but possibly also methi-
onine synthase reductase.
In conclusion, we have structurally characterized the
MMACHC-interacting module of MMADHC and demon-
strated that specific MMADHC mutations that cause com-
bined loss of AdoCbl and MeCbl production in cells can inter-
fere withMMACHC interaction. Further studies will clarify the
affinity of these proteins for each other, and how this protein-
protein interaction results in Cbl delivery in the cellular
context.
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